Cover Image
市場調查報告書

Capecitabine的中國市場

Investigation Report on China Capecitabine Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332763
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Capecitabine的中國市場 Investigation Report on China Capecitabine Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

F. Hoffmann-La Roche Ltd所開發的Capecitabine,1998年在美國,加拿大及瑞典市場以Xeloda的商品名登場,此後2年擴展到80以上的國家與地區。Capecitabine自打入中國市場以來其銷售量急速擴大,2010年不到1億人民幣的銷售量到2014年已達6億3500萬人民幣的規模。

本報告提供中國的Capecitabine市場規模與今後預測,提供您主要製藥公司及劑型別市場佔有率,銷售價格等資訊。

第1章 Capecitabine的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國的Capecitabine的市場簡介

  • Capecitabine的專利及核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國的Capecitabine銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國的Capecitabine的主要製藥公司市場佔有率調查

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國的Capecitabine的劑型的相關調查

  • 劑型別市場佔有率:以銷售額為準
  • 劑型別市場佔有率:以銷售量為準

第6章 中國的醫院的Capecitabine的標準價格

  • Shanghai Roche Pharmaceutical Co., Ltd (Xeloda)
  • Qilu Pharmaceutical Co., Ltd (Zhuo Lun)
  • Jiangsu Hengrui Medicine Co., Ltd (Ai Bin)
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd

第7章 中國市場中Capecitabine的主要製藥公司

  • Qilu Pharmaceutical Co., Ltd
  • Shanghai Roche Pharmaceutical Co., Ltd
  • Jiangsu Hengrui Medicine Co., Ltd
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd

第8章 中國的Capecitabine的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506203

Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer has mainly relied on traditional cytotoxic drugs for years. Capecitabine, as orally-administered tablets, acts directly in intestine and drug concentration in the tumor tissues is higher than that in blood. Besides, it features flexible dose adjustments and compliant method of administration. All this has contributed to its market growth.

Capecitabine develops fast after entering China, annual sales value rising from less than CNY 100 million in 2005 to CNY 635 million in 2014 and CAGR reaching up to 25.3% during this period. Capecitabine enjoys a vast demand in China. Currently, there are mainly five manufacturers of capecitabine in China: Shanghai Roche Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd, among which Shanghai Roche Pharmaceutical Co., Ltd has the largest market share of over 95% with sales value exceeding CNY 600 million in 2014.

With the degradation of environment and lifestyle changes brought about by improved living standards, the incidence of cancer keeps increasing in China. Therefore, capecitabine has good prospects in China and its market size will keep growing.

Readers can get at least the following information from this report:

  • market share of manufacturers of capecitabine in China
  • price of capecitabine in Chinese market
  • major manufacturers of capecitabine in Chinese market
  • share of dosage forms of capecitabine in China
  • market outlook of capecitabine in China

The author suggests the following groups of people purchase this report:

  • manufacturers of antitumor drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Capecitabine

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Capecitabine in China

  • 2.1. Patent and Approval Status of Capecitabine in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Capecitabine in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Capecitabine in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Capecitabine in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Capecitabine in Chinese Hospitals in 2014

  • 6.1. Shanghai Roche Pharmaceutical Co., Ltd (Trade Name: Xeloda)
  • 6.2. Qilu Pharmaceutical Co., Ltd (Trade Name: Zhuo Lun)
  • 6.3. Jiangsu Hengrui Medicine Co., Ltd (Trade Name: Ai Bin)
  • 6.4. Chia Tai Tianqing Pharmaceutical Group Co., Ltd

7. Major Manufacturers of Capecitabine in Chinese Market, 2010-2014

  • 7.1. Qilu Pharmaceutical Co., Ltd
  • 7.2. Shanghai Roche Pharmaceutical Co., Ltd
  • 7.3. Jiangsu Hengrui Medicine Co., Ltd
  • 7.4. Chia Tai Tianqing Pharmaceutical Group Co., Ltd

8. Market Outlook of Capecitabine in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Charts

  • Chart Patent Status of Capecitabine in China
  • Chart Patent and Approval Status of Capecitabine in China
  • Chart Sales Status of Capecitabine in China, 2010-2014
  • Chart Sales Value of Capecitabine in China, 2010-2014
  • Chart Sales Value of Capecitabine in Some Regions in China, 2010-2014
  • Chart Sales Volume of Capecitabine in China, 2010-2014
  • Chart Sales Volume of Capecitabine in Some Regions in China, 2010-2014
  • Chart Market Share of TOP4 Manufacturers of Capecitabine for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Capecitabine Made by Shanghai Roche in China, 2010-2014
  • Chart Sales Value and Market Share of Capecitabine Made by Chia Tai Tianqing in China, 2010-2014
  • Chart Sales Value and Market Share of Capecitabine Made by Jiangsu Hengrui in China, 2010-2014
  • Chart Sales Value and Market Share of Capecitabine Made by Qilu Pharmaceutical in China, 2010-2014
  • Chart Sales Value and Market Share of Capecitabine Tablets in China, 2010-2014
  • Chart Sales Volume and Market Share of Capecitabine in China, 2010-2014
  • Chart Price of Capecitabine Made by Shanghai Roche Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Capecitabine Made by Qilu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Capecitabine Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Capecitabine Made by Jiangsu Aosaikang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top